These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 6452152)

  • 1. Assessment of extrapyramidal disorders.
    Marsden CD; Schachter M
    Br J Clin Pharmacol; 1981 Feb; 11(2):129-51. PubMed ID: 6452152
    [No Abstract]   [Full Text] [Related]  

  • 2. Basal ganglia disease.
    Marsden CD
    Lancet; 1982 Nov; 2(8308):1141-7. PubMed ID: 6128460
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathophysiology of movement disorders.
    Marsden CD
    Neurol Clin; 1984 Aug; 2(3):435-59. PubMed ID: 6241955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders.
    Crossman AR
    Neuroscience; 1987 Apr; 21(1):1-40. PubMed ID: 2955248
    [No Abstract]   [Full Text] [Related]  

  • 5. Transcranial magnetic stimulation in movement disorders.
    Berardelli A
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 51():276-80. PubMed ID: 10590960
    [No Abstract]   [Full Text] [Related]  

  • 6. Reflex recovery curves in extrapyramidal disorders.
    Sax DS; Johnson TL; Cooper IS
    Adv Neurol; 1976; 14():285-96. PubMed ID: 133596
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacology of extrapyramidal movement disorders.
    Klawans HL
    Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
    [No Abstract]   [Full Text] [Related]  

  • 8. Basal Ganglia dysfunctions in movement disorders: What can be learned from computational simulations.
    Schroll H; Hamker FH
    Mov Disord; 2016 Nov; 31(11):1591-1601. PubMed ID: 27393040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myoclonus and extrapyramidal diseases.
    Defebvre L
    Neurophysiol Clin; 2006; 36(5-6):319-25. PubMed ID: 17336776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disorders of higher motor function: changes in movement disorders with growth--age dependency of clinical findings in essential basal nuclei diseases].
    Segawa M
    Nihon Rinsho; 1987 Feb; 45(2):371-80. PubMed ID: 3553668
    [No Abstract]   [Full Text] [Related]  

  • 11. Movement disorders and Creutzfeldt-Jakob disease: a review.
    Maltête D; Guyant-Maréchal L; Mihout B; Hannequin D
    Parkinsonism Relat Disord; 2006 Mar; 12(2):65-71. PubMed ID: 16364674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapyramidal involuntary movements during sleep.
    Mano T; Shiozawa Z; Sobue I
    Electroencephalogr Clin Neurophysiol Suppl; 1982; (35):431-42. PubMed ID: 6956510
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of basal ganglia in rhythmic movement.
    Freund HJ; Hefter H
    Adv Neurol; 1993; 60():88-92. PubMed ID: 8420222
    [No Abstract]   [Full Text] [Related]  

  • 14. The neuropharmacology of tardive dyskinesia, spontaneous dyskinesia, and other dystonias.
    Stahl SM; Davis KL; Berger PA
    J Clin Psychopharmacol; 1982 Oct; 2(5):321-8. PubMed ID: 6127351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions.
    Clark GT; Ram S
    Dent Clin North Am; 2007 Jan; 51(1):225-43, viii-ix. PubMed ID: 17185068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogensis and medical treatment of extrapyramidal disease.
    Calne DB; Eisler T
    Med Clin North Am; 1979 Jul; 63(4):715-27. PubMed ID: 157413
    [No Abstract]   [Full Text] [Related]  

  • 17. End of lines and boxes.
    Albin RL
    Mov Disord; 2001 May; 16(3):405-6. PubMed ID: 11391733
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neurotransmitters, drugs and neuropsychiatric diseases (author's transl)].
    Relja M; Lackvoić Z
    Lijec Vjesn; 1979 Oct; 101(10):609-16. PubMed ID: 44538
    [No Abstract]   [Full Text] [Related]  

  • 19. The expanding universe of disorders of the basal ganglia.
    Obeso JA; Rodriguez-Oroz MC; Stamelou M; Bhatia KP; Burn DJ
    Lancet; 2014 Aug; 384(9942):523-31. PubMed ID: 24954674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current model of basal ganglia organization under scrutiny.
    Parent A; Cicchetti F
    Mov Disord; 1998 Mar; 13(2):199-202. PubMed ID: 9539330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.